Aalborg University

WorkWave Closes Out 2023 With Double-Digit Software Revenue Growth, Coupled with 98% Gross and 111% Net Software Retention, Positioning for Continued Success in 2024

Retrieved on: 
Thursday, February 1, 2024
ACH, Dynamic routing, DDI, Growth, Oracle Corporation, Aalborg University, ARR, Payment, Business analytics, Computer science, PeopleSoft, CRM, Andersen, Software as a service, Communications center, Business, ROI

"Its robust features seamlessly integrate into our daily operations, providing invaluable insights and enhancing customer relationships.

Key Points: 
  • "Its robust features seamlessly integrate into our daily operations, providing invaluable insights and enhancing customer relationships.
  • This success combines with WorkWave's focus on stability and profitability, allowing it to deliver with a consistency that is lacking among many software providers during these turbulent times.
  • "2023 was a challenging year for software companies, and I could not be more proud of the team.
  • Andersen has held executive leadership positions for fast-paced, global enterprise software and infrastructure companies for more than the past two decades.

IEEE EMBS Executive Committee Appoints Dr. Erika Ross Ellison as President-Elect, Along With Two New Vice Presidents

Retrieved on: 
Tuesday, December 19, 2023
Technology, Medical Devices, Science, Genetics, Biotechnology, Other Manufacturing, Health, Health Technology, Engineering, Other Science, Research, Nanotechnology, Manufacturing, Software, Hardware, Data Management, Artificial Intelligence, FH, Student, Biomedical sciences, Tetraplegia, Mayo Clinic, Electrical engineering, University, Machine learning, Bachelor of Science, Signal processing, UNSW, EMBC, Speech, Doctor of Philosophy, Conference, Texas A&M University, Telstra, Clinical, Telecommunications, Biology, School, Student activities, Woman, DRS, Applied science, University of Freiburg, Molecular biology, Quality, American Speech, Neurosurgery, Growth, Aalborg University, Medical device

Beena Ahmed and Natalie Mrachacz-Kersting were elected vice president of Conferences and vice president of Member and Student Activities, respectively.

Key Points: 
  • Beena Ahmed and Natalie Mrachacz-Kersting were elected vice president of Conferences and vice president of Member and Student Activities, respectively.
  • “My top objective will be to establish IEEE EMBS as the largest global forum for biomedical engineers, clinicians and scientists,” said Dr. Ross Ellison.
  • She is the technical representative on the IEEE EMBS administrative committee, and served as program co-chair of EMBC 2023.
  • She is an IEEE EMBS practitioner representative, and is active on the IEEE Brain steering committee.

Aalborg Portland and Fidelis New Energy enter into letter of intent for onshore CO2 storage

Retrieved on: 
Thursday, June 8, 2023
Carbon, Research, CCO, New energy, Aalborg University, Plant, Fidelis, Climate, Entrepreneurship, Port of Aalborg, Letter, Greenhouse, CO2, Cement, Coal, Aalborg Portland, Norne oil field

COPENHAGEN, Denmark and AALBORG, Denmark, June 8, 2023 /PRNewswire/ -- Aalborg Portland and Fidelis New Energy (Fidelis) have entered into a letter of intent for safe and permanent storage of Aalborg Portland's CO2 emissions utilizing Fidelis' recently announced Norne Carbon Storage Hub (Norne) in Aalborg. This agreement is a milestone accomplishment for the decarbonization of cement production, making Aalborg Portland an industry leader in carbon impact and further demonstrating Denmark's commitment to being a global leader in decarbonizing hard to abate industries.

Key Points: 
  • COPENHAGEN, Denmark and AALBORG, Denmark, June 8, 2023 /PRNewswire/ -- Aalborg Portland and Fidelis New Energy (Fidelis) have entered into a letter of intent for safe and permanent storage of Aalborg Portland's CO2 emissions utilizing Fidelis' recently announced Norne Carbon Storage Hub (Norne) in Aalborg.
  • Fidelis' facility is planned to be established just a few kilometers from Aalborg Portland, and therefore, this letter of intent makes a lot of sense", says Michael Lundgaard Thomsen, CCO of Aalborg Portland.
  • On 15 May 2023, Fidelis announced the Norne Carbon Storage Hub, an onshore CO2 storage network in Denmark for CO2 storage with plants in both Aalborg and Kalundborg.
  • "It is fantastic that Fidelis and Aalborg Portland are joining forces on CO2 capture and storage in Aalborg.

Aalborg Portland and Fidelis New Energy enter into letter of intent for onshore CO2 storage

Retrieved on: 
Thursday, June 8, 2023
Carbon, Research, CCO, New energy, Aalborg University, Plant, Fidelis, Climate, Entrepreneurship, Port of Aalborg, Letter, Greenhouse, CO2, Cement, Coal, Aalborg Portland, Norne oil field

COPENHAGEN, Denmark and AALBORG, Denmark, June 8, 2023 /PRNewswire/ -- Aalborg Portland and Fidelis New Energy (Fidelis) have entered into a letter of intent for safe and permanent storage of Aalborg Portland's CO2 emissions utilizing Fidelis' recently announced Norne Carbon Storage Hub (Norne) in Aalborg. This agreement is a milestone accomplishment for the decarbonization of cement production, making Aalborg Portland an industry leader in carbon impact and further demonstrating Denmark's commitment to being a global leader in decarbonizing hard to abate industries.

Key Points: 
  • COPENHAGEN, Denmark and AALBORG, Denmark, June 8, 2023 /PRNewswire/ -- Aalborg Portland and Fidelis New Energy (Fidelis) have entered into a letter of intent for safe and permanent storage of Aalborg Portland's CO2 emissions utilizing Fidelis' recently announced Norne Carbon Storage Hub (Norne) in Aalborg.
  • Fidelis' facility is planned to be established just a few kilometers from Aalborg Portland, and therefore, this letter of intent makes a lot of sense", says Michael Lundgaard Thomsen, CCO of Aalborg Portland.
  • On 15 May 2023, Fidelis announced the Norne Carbon Storage Hub, an onshore CO2 storage network in Denmark for CO2 storage with plants in both Aalborg and Kalundborg.
  • "It is fantastic that Fidelis and Aalborg Portland are joining forces on CO2 capture and storage in Aalborg.

Dopavision Appoints Prof. Dr. Jens Ellrich as Chief Scientific Officer

Retrieved on: 
Tuesday, March 21, 2023
WISE, University, Therapy, EBS, Editorial, Research, Doctor of Philosophy, Aalborg University, Medical school, RWTH Aachen University, Eye, MD, European Journal, Pharmaceutical industry, Neuroscience, Pain

Berlin, Germany, March 21, 2023 --- Dopavision, a clinical-stage company pioneering the development of digitally delivered light-based therapeutics, today announced the appointment of Prof. Dr. Jens Ellrich as Chief Scientific Officer. Jens Ellrich brings a wealth of scientific knowledge and extensive experience in digital therapeutics, including new product development. He will spearhead Dopavision’s ambitious research and development activities for the Company’s lead product, MyopiaX®, Dopavision’s leading-edge digital therapeutic for childhood myopia control. The first-in-human clinical investigation of MyopiaX® is ongoing across Europe.

Key Points: 
  • Berlin, Germany, March 21, 2023 --- Dopavision , a clinical-stage company pioneering the development of digitally delivered light-based therapeutics, today announced the appointment of Prof. Dr. Jens Ellrich as Chief Scientific Officer.
  • Jens Ellrich brings a wealth of scientific knowledge and extensive experience in digital therapeutics, including new product development.
  • Jens joined the medical device industry in 2010 and served, among others, as Chief Medical Officer for the neurotechnology companies Cerbomed, Sapiens, EBS Technologies, and WISE.
  • “I am thrilled to join Dopavision at this pivotal and exciting time to support the development of a light-based treatment for myopia.”

Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases

Retrieved on: 
Wednesday, February 22, 2023
Health, Other Health, Other Science, Pharmaceutical, Science, Biotechnology, Marketing, Clinical trial, Pfizer, Therapy, Doctor of Philosophy, Growth, Lipid metabolism, Drug development, IND, DSM-IV codes, Fatty liver disease, ASO, Club, NAFLD, Small RNA, Aalborg University, Novartis, RNA, Obesity, Pharmaceutical industry

Resalis Therapeutics today announced its completion of the seed financing round of €10 million to establish a non-coding RNA (ncRNA)-based therapeutic approach for the treatment of metabolic diseases.

Key Points: 
  • Resalis Therapeutics today announced its completion of the seed financing round of €10 million to establish a non-coding RNA (ncRNA)-based therapeutic approach for the treatment of metabolic diseases.
  • The financing was led by Claris Ventures, with participation from Italian Angels for Growth and Club degli Investitori.
  • Concurrent with the round, Pietro Puglisi, Managing Partner at Claris Ventures, joins Resalis’ Board of Directors.
  • Both have a deep understanding in the field of ncRNAs and RNA-targeted therapeutics in human health and metabolic disorders.

Vertimass Partners with Team to Convert Carbon Dioxide into Jet Fuel through Danish Government Award

Retrieved on: 
Thursday, December 8, 2022
Hydrogen, UT–Battelle, Demonstration, Hydrocarbon, Aircraft, Gasoline, Transport, Risk, Aalborg Airport, LPG, Oak Ridge National Laboratory, Alcohol, Investment, Aalborg University, Ethanol, Petroleum, Biomass, Aviation, Methanol, Carbon, Organization, Renewable energy, Russia in the European energy sector

IRVINE, Calif., Dec. 8, 2022 /PRNewswire/ -- Vertimass, with the mission to commercialize breakthrough sustainable fuels that reduce carbon emissions, announced today that a consortium with whom it is partnering has been awarded approximately $1.35 million to pilot the conversion of green hydrogen and carbon dioxide into sustainable aviation fuel. The funds were granted by the Energy Technology Development and Demonstration Programme (EUDP) in Denmark.

Key Points: 
  • "The conversion of carbon dioxide a major greenhouse gas contributor into jet fuel and other hydrocarbons can play a vital role in reducing the carbon footprint for transportation," said Vertimass President and CEO Dr. Charles Wyman.
  • "We are honored to be part of this award and look forward to working with all of the organizations involved."
  • Each company will oversee a different step in the process, working together to transform carbon dioxide into jet fuel.
  • Kosan Gas, the Nordic region's leading gas supplier, will sell coproduced renewable LPG; Aalborg Airport will use the sustainable jet fuel; European Energy, a leading developer of green energy solutions, will convert the carbon dioxide into methanol; and Vertimass will convert the methanol into jet fuel.

ATLANT 3D Nanosystems Developing a Space-certified Nanofabricator 0G

Retrieved on: 
Thursday, March 31, 2022
Engineering, Consumer Electronics, Technology, Manufacturing, Nanotechnology, Other Technology, Hardware, ATLANT, ESA, Materials International Space Station Experiment, Aalborg University, STMicroelectronics, NASA, SUPSI, International Space Station, Institute of technology, SAS, Industry, Technology, DTU, Technical University of Denmark, Aarhus University, ISS, Electronics, FAU, Education, University, TNO, Merck, 3D printing, Space, Science, Danish

ATLANT 3D Nanosystems announces today the collaboration with ESA BIC to further advance the development of ATLANT 3D Nanofabricator 0G systems, the first-ever zero gravity R&D system that allows selective area direct write atomic layer precision.

Key Points: 
  • ATLANT 3D Nanosystems announces today the collaboration with ESA BIC to further advance the development of ATLANT 3D Nanofabricator 0G systems, the first-ever zero gravity R&D system that allows selective area direct write atomic layer precision.
  • ATLANT 3D will develop a space-certified Nanofabricator 0G with the goal of going to the International Space Station (ISS) in future missions.
  • ATLANT 3D is a Danish startup company that is developing a fundamentally different and innovative micro and nanofabrication platform technology.
  • ATLANT 3D is a developer of high-performance technology enables atomical precise advanced manufacturing of the next generation of advanced materials and electronics.

Roku Joins Sound Hub Denmark

Retrieved on: 
Wednesday, February 23, 2022
Software, Audio, Video, TV and Radio, Advertising, Communications, Consumer Electronics, Technology, Entertainment, Acoustics, Bang & Olufsen, DSP, Aalborg University, Name, NASDAQ, Environment, Mentorship, Roku, Inc., Acceleration, Love, Harman, CEO, Cassette tape, Sound, Roku, Dynaudio, Engineering, Roku, Sound Hub Denmark, Roku, SOUND HUB DENMARK

Roku, Inc. (NASDAQ: ROKU) and Sound Hub Denmark today announced Rokus membership and participation in Sound Hub Denmark , a world-class sound and acoustics growth hub designed to foster innovation within the field of audio.

Key Points: 
  • Roku, Inc. (NASDAQ: ROKU) and Sound Hub Denmark today announced Rokus membership and participation in Sound Hub Denmark , a world-class sound and acoustics growth hub designed to foster innovation within the field of audio.
  • As a leading streaming platform and provider of innovative sound solutions designed to provide inspiring home theater audio, Roku is a welcome addition to the Sound Hub, said Peter Petersen, CEO of Sound Hub Denmark.
  • Sound Hub Denmark is the worlds first international sound technology and innovation hub providing a focused, world-class workplace and sound and acoustics growth hub for start-ups, freelancers, SMEs, and corporations, all with the ambition to be world-class within their field.
  • Sound Hub Denmarks vision is to be a global powerhouse for sound innovation the worlds best place to start and scale innovative sound businesses of tomorrow.

AlgoTherapeutix appoints Prof Jens Ellrich Chief Medical Officer

Retrieved on: 
Monday, November 8, 2021
Biotechnology, Pharmaceutical, Health, University, EBS, European Journal of Pain, Charles V European Award, MD, Neuroscience, CEO, Doctor of Philosophy, Peripheral neuropathy, Research, Editorial, University of Erlangen–Nuremberg, Peer review, Publication, RWTH Aachen University, European Journal, Aalborg University, WISE, Pharmaceutical industry

Jens Ellrich, MD, PhD, spent 18 years in basic and clinical pain research at University hospitals in Germany and Denmark with a track record of more than 85 publications in scientific journals with peer review.

Key Points: 
  • Jens Ellrich, MD, PhD, spent 18 years in basic and clinical pain research at University hospitals in Germany and Denmark with a track record of more than 85 publications in scientific journals with peer review.
  • Since 2010, Jens has served as Chief Medical Officer for the international neuroscience start-ups Cerbomed, EBS Technologies, Precisis, Sapiens, and WISE.
  • Jens brings a wealth of hands-on experience and expertise in pain research, clinical development, and medical affairs.
  • About AlgoTherapeutix : AlgoTherapeutix is a French biotech founded in 2018 to develop innovative solutions for complex pain.